During the opening ceremony of the BIO Asia-Taiwan Exhibition yesterday in Taipei, President Tsai Ing-wen (蔡英文) expressed the hope that advancements in Taiwan’s biotechnology industry would usher in major business opportunities from abroad, allowing the sector to reach NT$1 trillion (US$339.50 billion) in annual production.
Despite COVID-19, the annual biotech trade show attracted pharmaceutical and medical device companies from more than 500 nations, including the US, the UK, Australia, Switzerland and Malaysia.
The five-day exhibition is the first in-person international biotechnology trade show in Asia since the outbreak of COVID-19.
Photo: Chien Jung-fong, Taipei Times
Speaking at the opening ceremony, Tsai said that biotechnology is a crucial part of the “five plus two” innovative industries plan that she introduced during her first term, adding that she hopes the exhibition would be a platform for the nation to demonstrate innovativeness and accelerate the development of its biotech sector.
The nation would deregulate relevant laws to expedite the growth of the sector, she said.
The “five plus two” innovative industries plan refers to an initiative to develop an Asian equivalent of the US’ Silicon Valley, including biotech, green energy, industry 4.0, robotics, defense and aviation, as well as innovative agriculture and a circular economy.
Taiwan’s biomedical industry grew by 8.7 percent in annual revenue last year, a record high over the past few years, with the amount of capital invested reaching NT$55.1 billion, Tsai said, adding that digital medicine and precision medicine, two sectors that have shown great potential in recent years, are expected to grow significantly.
Cell therapy, regenerative medicine and genetic testing combined with big data analysis are also areas that have progressed a lot, while innovative medical devices, including nanomedical technology, are expected to receive more attention, she said.
New medicine development has also had breakthroughs, Tsai said, citing a licensing agreement signed in April by Taiwan’s Oneness Biotech Co Ltd and the Denmark-based Leo Pharma, a global leader in medical dermatology.
The agreement was signed to facilitate the development and introduction to the market of FB825, a drug candidate for novel atopic dermatitis and asthma, with an upfront payment to Oneness totaling US$530 million, the highest a Taiwanese company has ever received in such a deal.
Meanwhile, the National Biotechnology Research Park in collaboration with several multi-national pharmaceutical companies, accelerators and venture capital firms yesterday opened an accelerator hub for biomedical start-ups.
Speaking at the inauguration ceremony of the hub, former vice president Chen Chien-jen (陳建仁) said that the new facilities provide one-stop services to cultivate biomedical start-ups and has the potential to become the biggest accelerator hub in the field of biomedicine in the Asia-Pacific region.
The occupancy rate of biomedical companies at the park is 60 percent and the number is expected to reach 80 percent by the end of the year, Chen said, adding that growth at such a rate would be “beyond my imagination.”
Additional reporting by Chien Hui-ju
Three batches of banana sauce imported from the Philippines were intercepted at the border after they were found to contain the banned industrial dye Orange G, the Food and Drug Administration (FDA) said yesterday. From today through Sept. 2 next year, all seasoning sauces from the Philippines are to be subject to the FDA’s strictest border inspection, meaning 100 percent testing for illegal dyes before entry is allowed, it said in a statement. Orange G is an industrial coloring agent that is not permitted for food use in Taiwan or internationally, said Cheng Wei-chih (鄭維智), head of the FDA’s Northern Center for
The Chinese military has built landing bridge ships designed to expand its amphibious options for a potential assault on Taiwan, but their combat effectiveness is limited due to their high vulnerability, a defense expert said in an analysis published on Monday. Shen Ming-shih (沈明室), a research fellow at the Institute for National Defense and Security Research, said that the deployment of such vessels as part of the Chinese People’s Liberation Army (PLA) Navy’s East Sea Fleet signals a strong focus on Taiwan. However, the ships are highly vulnerable to precision strikes, which means they could be destroyed before they achieve their intended
About 4.2 million tourist arrivals were recorded in the first half of this year, a 10 percent increase from the same period last year, the Tourism Administration said yesterday. The growth continues to be consistent, with the fourth quarter of this year expected to be the peak in Taiwan, the agency said, adding that it plans to promote Taiwan overseas via partnerships and major events. From January to June, 9.14 million international departures were recorded from Taiwan, an 11 percent increase from the same period last year, with 3.3 million headed for Japan, 1.52 million for China and 832,962 to South Korea,
REWRITING HISTORY: China has been advocating a ‘correct’ interpretation of the victory over Japan that brings the CCP’s contributions to the forefront, an expert said An elderly Chinese war veteran’s shin still bears the mark of a bullet wound he sustained when fighting the Japanese as a teenager, a year before the end of World War II. Eighty years on, Li Jinshui’s scar remains as testimony to the bravery of Chinese troops in a conflict that killed millions of their people. However, the story behind China’s overthrow of the brutal Japanese occupation is deeply contested. Historians broadly agree that credit for victory lies primarily with the Chinese Nationalist Party (KMT)-led Republic of China (ROC) Army. Its leader, Chiang Kai-shek (蔣介石), fled to Taiwan in 1949 after losing a
RSS